In Vitro Anti-Proliferative and Cisplatin-Modulating Effects of Cedrus libani A. Rich Leaf Essential Oil on H460 and HT-29 Human Cancer Cell Lines
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27209044 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Hicham Younes und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Science, Beirut Arab University, Debbieh, Beirut 11072809, Lebanon. Hauptthemen laut MEDLINE: Oils, Volatile, Cisplatin, Plant Leaves, Cedrus. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cedrus libani A. Rich is a coniferous tree native to the eastern Mediterranean region that is known for exhibiting pharmacological properties. In the present study, we investigated the anti-proliferative effect of C. libani leaf essential oil (EO) against H460 and HT-29, as well as evaluated its chemo-modulatory effect with cisplatin (CIS). The EO chemical profile was analyzed via GC-MS. Cell viability was assessed using MTT, while trypan blue exclusion and Annexin V/Propidium Iodide staining were employed to detect cell death. Colony biomass and wound closure were evaluated using crystal violet staining and a scratch assay, respectively. Nuclear morphology and reactive oxygen species (ROS) were assessed using DAPI staining and an NBT assay, respectively. EO and CIS individually reduced cell viability in a time- and concentration-dependent manner with combination treatments demonstrating synergistic/additive/antagonistic interactions depending on the combination ratio, cell line and time point. EO alone does not exhibit significant cell death, whereas CIS demonstrated significant apoptosis and necrosis. The combination (IC50:IC50) enhanced cell death, particularly in HT-29. Both EO and CIS reduced colony biomass and wound closure, with the combination showing higher inhibitory effect on colony biomass in both cell lines and enhanced wound closure inhibitory effect in HT-29 but reduced effect in H460. CIS and combination caused more notable nuclear alterations compared to EO alone, whereas an early increase in NBT reduction followed by a subsequent decrease was observed for individual treatments as well as the combination. This study provides insights into the antiproliferative and chemo-modulatory potential of C. libani leaf essential oil, although further studies are needed to elucidate the underlying molecular mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Science, Beirut Arab University, Debbieh, Beirut 11072809, Lebanon.
- Molecular and Translational Medicine Laboratory, Faculty of Medicine, Beirut Arab University, Beirut 11072809, Lebanon.
- Thumbay Research Institute for Precision Medicine, Gulf Medical University, Ajman 4184, United Arab Emirates.
- Department of Physical Sciences, Lebanese American University, Beirut 11022801, Lebanon.
ORCID-Profile: Hicham Younes, Rania Zaarour, Nathalie Hayeck, Jamilah Borjac
Zitieren
APA
Younes, H., Azakir, B., Zaarour, R., Hayeck, N., & Borjac, J. (2026). In Vitro Anti-Proliferative and Cisplatin-Modulating Effects of Cedrus libani A. Rich Leaf Essential Oil on H460 and HT-29 Human Cancer Cell Lines. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27209044
Vancouver
Younes H, Azakir B, Zaarour R, Hayeck N, Borjac J. In Vitro Anti-Proliferative and Cisplatin-Modulating Effects of Cedrus libani A. Rich Leaf Essential Oil on H460 and HT-29 Human Cancer Cell Lines. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27209044
BibTeX
@article{Younes2026,
author = {Younes, Hicham and Azakir, Bilal and Zaarour, Rania and Hayeck, Nathalie and Borjac, Jamilah},
title = {In Vitro Anti-Proliferative and Cisplatin-Modulating Effects of Cedrus libani A. Rich Leaf Essential Oil on H460 and HT-29 Human Cancer Cell Lines},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27209044}
}
EUVIMED